Replies to post #128509 on Avid Bioservices Inc (CDMO)

[investingdog]

This is, IMO, a bad news for Bavi. They are already running p3 trial and will have to enroll only 264 patients, while PPHM needs 600. That p3 trial will finish at least 1 year before Bavi unless we get accelerated approval. PPHM management is dragging their feet, they should start p3 immediately and could possibly partner later with trial in progress.